TGFB1I1 and cancer: Similarly, TGF-\documentclass[12pt]{minimal}\usepackage{amsmath}\usepackage{wasysym}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{amsbsy}\usepackage{upgreek}\usepackage{mathrsfs}\setlength{\oddsidemargin}{-69pt}\begin{document}}{}$\beta $\end{document} (TGFB1I1) is a known immune suppressor [66] and its high activation in ICR-D cancers suggests the occurrence of phenomenon, such as immune exhaustion, leading to poor survival rates in these ICR-H tumor samples.